Mount Yale Investment Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
CIP
FLAM
DSCM
Mount Yale Investment Advisors's ATRC Position: Q3 2024 in Review
Mount Yale Investment Advisors sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 9,743 shares — an estimated $222K sold.
Mount Yale Investment Advisors first reported a position in ATRC in Q4 2020 and held it in 14 quarters. The position peaked at $349K in Q2 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.
- Mount Yale Investment Advisors reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
- Mount Yale Investment Advisors sold 9,743 AtriCure shares in Q3 2024, an estimated $222K.
- Mount Yale Investment Advisors first reported a position in AtriCure in Q4 2020 and held it in 14 quarters.
- Mount Yale Investment Advisors's AtriCure position peaked at $349K in Q2 2021.
- 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.
Based on Mount Yale Investment Advisors's 13F filing for Q3 2024, filed 23 Oct 2024.